文献速递妇科生殖医学

微生物组与女性慢性盆腔疼痛:小型综述

Microbiome and chronic pelvic pain in women: a mini-review.
PubMed 文献 · Hum Reprod · 2026-01-01

该综述整合观察性、多组学和机制证据,探讨肠道、阴道、泌尿道及子宫内膜微生态失调通过免疫失调、内分泌失衡和中枢敏化等通路参与慢性盆腔疼痛。多部位菌群改变常并存但解剖学迥异,厌氧菌群变化与宫颈阴道免疫特征支持微生物-免疫交互。文章评估了微生物组靶向干预的转化机会与局限。

要点

  • 慢性盆腔疼痛涉及多系统重叠疾病,共享免疫失调、内分泌失衡和中枢敏化通路。
  • 肠道、阴道、泌尿道和子宫内膜菌群失调可能通过代谢物和神经免疫信号促进慢性疼痛。
  • 微生物组靶向干预需纵向、生物标志物嵌入的试验支持机制分层和治疗开发。

核心结论

  • 微生物组失调可能是慢性盆腔疼痛相关生物学通路上游调节因素,但因果证据有限。

研究设计与样本

  • 叙述性小型综述,综合观察性研究、多组学证据、机制研究和实验模型数据。

主要发现

  • 慢性盆腔疼痛涵盖子宫内膜异位症/子宫腺肌病、膀胱疼痛综合征/间质性膀胱炎、肠易激综合征、外阴痛和肌筋膜疼痛综合征等重叠疾病。
  • 肠道、阴道、泌尿道和子宫内膜微生态失调可能促进局部和全身炎症、损害上皮屏障、通过雌激素组改变雌激素再循环并参与异常神经免疫信号。
  • 近期多部位分析提示微生物改变常跨盆腔腔室共存但保持解剖学差异,厌氧菌群变化与宫颈阴道免疫特征配对支持微生物-免疫交互。
  • 微生物代谢物被强调为关键功能介质,实验模型提供了一定因果数据。

临床怎么用

  • 临床可关注微生物组靶向干预如饮食调节、益生菌/精神益生菌、后生元和菌群移植方法的转化潜力。
  • 需开展协调一致的纵向和生物标志物嵌入试验,以实现基于机制的分层和合理治疗开发。

局限性

  • 综述指出需协调一致的纵向和生物标志物嵌入试验,暗示现有证据在因果性和标准化方面存在不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic pelvic pain (CPP) is a prevalent, disabling syndrome encompassing overlapping disorders such as endometriosis/adenomyosis, bladder pain syndrome/interstitial cystitis, irritable bowel syndrome, vulvodynia, and myofascial pain syndrome. Despite distinct clinical phenotypes, these conditions converge on shared biological axes-immune dysregulation, endocrine imbalance, and central sensitization-that sustain chronic pain. Increasing evidence implicates the human microbiome as a potential upstream regulator of these pathways. Dysbiosis across the gut, vaginal, urinary, and endometrial microbial ecosystems may promote local and systemic inflammation, compromise epithelial barrier integrity, alter estrogen recirculation through the estrobolome, and engage aberrant neuroimmune signalling along gut-brain and hypothalamic-pituitary-ovarian circuits. Recent multi-site profiling suggests that microbial alterations often co-occur across pelvic compartments but remain anatomically distinct, with shifts in anaerobic taxa and paired cervicovaginal immune signatures supporting microbiome-immune interactions in CPP pathophysiology. This narrative review synthesizes observational, multi-omics, and mechanistic evidence linking microbial dysbiosis to CPP, highlights microbial metabolites as key functional mediators, and evaluates causal data from experimental models. Finally, it discusses translational opportunities and limitations, including microbiome-targeted interventions (dietary modulation, probiotics/psychobiotics, postbiotics, and microbiota transfer approaches) and the need for harmonized, longitudinal and biomarker-embedded trials to enable mechanism-based stratification and rational therapeutic development.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Vibert J, Stojanov M, Da Silva T, et al. Microbiome and chronic pelvic pain in women: a mini-review. Hum Reprod. 2026. PMID: 42497358. doi:10.1093/humrep/deag110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。